In last trading session, Caredx Inc (NASDAQ:CDNA) saw 0.9 million shares changing hands with its beta currently measuring 1.95. Company’s recent per share price level of $22.29 trading at -$1.09 or -4.66% at ring of the bell on the day assigns it a market valuation of $1.20B. That closing price of CDNA’s stock is at a discount of -56.3% from its 52-week high price of $34.84 and is indicating a premium of 66.71% from its 52-week low price of $7.42.
For Caredx Inc (CDNA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.89. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.15 in the current quarter.
Caredx Inc (NASDAQ:CDNA) trade information
Upright in the red during last session for losing -4.66%, in the last five days CDNA remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $22.29 price level, adding 12.76% to its value on the day. Caredx Inc’s shares saw a change of 4.11% in year-to-date performance and have moved -10.27% in past 5-day. Caredx Inc (NASDAQ:CDNA) showed a performance of -3.88% in past 30-days.
Wall Street analysts have assigned a consensus price target of 35 to the stock, which implies a rise of 36.31% to its current value. Analysts have been projecting 35 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -57.02% in reaching the projected high whereas dropping to the targeted low would mean a loss of -57.02% for stock’s current value.
Caredx Inc (CDNA) estimates and forecasts
This year revenue growth is estimated to rise 18.52% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 84.56M for the same. And 6 analysts are in estimates of company making revenue of 85.31M in the next quarter. Company posted 65.57M and 72.05M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -21.96% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 74.72% while estimates for its earnings growth in next 5 years are of 73.75%.
Caredx Inc (NASDAQ:CDNA)’s Major holders
ARK INVESTMENT MANAGEMENT LLC is the top institutional holder at CDNA for having 5.7 million shares of worth $88.56 million. And as of 2024-06-30, it was holding 10.925 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 5.29 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.1283 of outstanding shares, having a total worth of $82.1 million.
On the other hand, ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.38 shares of worth $52.95 million or 4.43% of the total outstanding shares. The later fund manager was in possession of 1.52 shares on Sep 30, 2024 , making its stake of worth around $33.83 million in the company or a holder of 2.83% of company’s stock.
